Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

06/28 22:14   U.S. destroyer rudely breaches international rules, allowing itself dangerous approach with Russian warship in Mediterranean Sea - Russian Defense Ministry (Part 2)
 
06/28 22:02   Russian MPs to take part in PACE only if given back their powers in full - Naryshkin
 
06/28 21:44   Moscow court arrests Russian Authors' Society general director at least until Aug 17 (Part 2)
 
06/28 21:39   Defense to appeal Russian Authors' Society head's arrest - lawyer
 
06/28 21:38   Russia, Kazakhstan may sign intergovernmental agreement on cooperation for better information security - Russia Security Council
 
06/28 20:44   Moscow court arrests Russian Authors' Society general director
 
06/28 20:35   Brexit is element of EU's erosion, may destabilize EU structure - Duma chairman
 
06/28 20:31   Lawyer for Russian Authors' Society chief believes his criminal case ill-founded
 
06/28 20:26   LDPR to run in elections under slogan: "Enough to humiliate Russians"
 
06/28 20:13   Duma Chairman Naryshkin sees Turkey's apologies for downed Russian plane as positive step
 




 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

June 28, 2016
 
22:14
U.S. destroyer rudely breaches international rules, allowing itself dangerous approach with Russian warship in Mediterranean Sea - Russian Defense Ministry (Part 2)
 
22:02
Russian MPs to take part in PACE only if given back their powers in full - Naryshkin
 
21:44
Moscow court arrests Russian Authors' Society general director at least until Aug 17 (Part 2)
 
21:39
Defense to appeal Russian Authors' Society head's arrest - lawyer
 
21:38
 
20:44
Moscow court arrests Russian Authors' Society general director
 
20:35
Brexit is element of EU's erosion, may destabilize EU structure - Duma chairman
 
20:31
Lawyer for Russian Authors' Society chief believes his criminal case ill-founded
 
20:26
LDPR to run in elections under slogan: "Enough to humiliate Russians"
 
20:13
Duma Chairman Naryshkin sees Turkey's apologies for downed Russian plane as positive step
 
20:02
RTS tops 900 pts amid global advance; Mechel leads on corporate news
 
19:54
Russia, Turkey should gradually normalize relations - Duma chairman
 
19:53
Heads of Russian, Turkish delegations to PABSEC address restoration of Russian-Turkish relations
 
19:52
Main indexes of the Russia stock market for June 28
 
 more headlines 



Interviews
 

.
Israeli Prime Minister Benjamin Netanyahu has given an interview to Interfax ahead of his visit to Russia in which he speaks about the influence that his personal relationship with Russian President Vladimir Putin have on the development of interstate ties, about Israels plans regarding new gas fields and said that Israel will into allow Syria to turn into a source of aggression. This will be Netanyahus third visit in under a year.

more
.
.
Indonesian Ambassador to Russia Wahid Supriyadi has given an interview with Interfax in which he speaks about the results of the Russia-ASEAN summit, prospects for achieving an agreement on oil production freeze in OPEC, Indonesian-Russian military and technological cooperation and the launch of direct air communication between Indonesia and Russia.

more
.
.
U.S. Department of State Special Envoy and Coordinator for International Energy Affairs Amos Hochstein has given an interview to Interfax‘s special correspndent in the United States Ksenia Baygarova in which he speaks about why the United States has started to export oil and gas, how realistic the intention of oil producing countries to freeze oil production is, and how U.S. energy companies react to sanctions against Russia.

more

 
  
 ©   1991—2016   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100